Chempass Company
ChemPass was founded to develop AI technologies and software for the design of novel small organic molecules and scaffolds. ChemPass' technologies utilize synthetic artificial intelligence for template design, in silico reaction planning and evaluation, a chemistry know-how database and several other custom solutions.
%20.jpg)
Investment Stage:
N/A
Funding Status:
Seed
Headquarters:
Budapest, Budapest, Hungary
Industry:
Drug Discovery
Number Of Exists:
N/A
Investor Type:
N/A
Technology:
Drug Design
Employee Number:
Undisclosed
Founded Date:
2016